|
Delayed
NSE India S.E.
01:23:44 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 84.83 INR | -0.22% |
|
+0.01% | +15.70% |
| Market Cap | 957M 10.03M 8.61M 8.06M 7.38M 13.9M 13.94M 95.4M 37.29M 483M 37.64M 36.83M 1.6B | P/E 2024 |
19.5x | P/E 2025 | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.38B 24.88M 21.36M 20M 18.31M 34.49M 34.59M 237M 92.56M 1.2B 93.42M 91.4M 3.96B | EV / Sales 2024 |
0.78x | EV / Sales 2025 | 0.9x |
| Free-Float |
34.72% | Yield 2024 |
1.32% | Yield 2025 | 1.44% |
| 1 day | -0.22% | ||
| 1 week | +0.01% | ||
| Current month | -3.70% | ||
| 1 month | -4.29% | ||
| 3 months | -8.11% | ||
| 6 months | +11.31% | ||
| Current year | +15.70% |
| 1 week | 84.01 | 87.9 | |
| 1 month | 84.01 | 93 | |
| Current year | 60 | 98.85 | |
| 1 year | 60 | 98.85 | |
| 3 years | 60 | 157.98 | |
| 5 years | 60 | 157.98 | |
| 10 years | 23 | 157.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | - | |
| Director of Finance/CFO | - | 2023-06-01 | |
Shreepada M. L.
CMP | Compliance Officer | - | 2026-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2011-06-29 | |
| Director/Board Member | 65 | 2019-09-27 | |
Nicola Neeladri
BRD | Director/Board Member | - | 2020-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.22% | +0.01% | - | - | 14.08M | ||
| -1.12% | -5.49% | +60.19% | +112.43% | 1,048B | ||
| -1.57% | -0.60% | +50.33% | +59.86% | 640B | ||
| -1.81% | -1.41% | +24.07% | +75.98% | 456B | ||
| -1.17% | -2.10% | +38.61% | +40.43% | 362B | ||
| -2.00% | -1.35% | +22.22% | +38.92% | 295B | ||
| -0.98% | +0.53% | +2.04% | +12.13% | 255B | ||
| -0.76% | +0.75% | +51.75% | +70.45% | 236B | ||
| -3.18% | -0.30% | -17.23% | -53.79% | 204B | ||
| +0.52% | +3.78% | +30.67% | +93.68% | 185B | ||
| Average | -1.23% | -0.72% | +29.18% | +50.01% | 409.07B | |
| Weighted average by Cap. | -1.36% | -1.92% | +38.50% | +66.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.39B 35.52M 30.49M 28.54M 26.14M 49.24M 49.38M 338M 132M 1.71B 133M 130M 5.66B | 3.03B 31.73M 27.24M 25.5M 23.35M 43.99M 44.12M 302M 118M 1.53B 119M 117M 5.06B |
| Net income | 73.92M 774K 664K 622K 570K 1.07M 1.08M 7.37M 2.88M 37.26M 2.91M 2.84M 123M | 72.15M 755K 648K 607K 556K 1.05M 1.05M 7.19M 2.81M 36.36M 2.84M 2.78M 120M |
| Net Debt | 1.22B 12.81M 10.99M 10.29M 9.42M 17.75M 17.8M 122M 47.65M 616M 48.09M 47.05M 2.04B | 1.42B 14.86M 12.75M 11.94M 10.93M 20.6M 20.65M 141M 55.27M 715M 55.78M 54.58M 2.37B |
Employees
986
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | ₹84.83 | -0.22% | 1,886 |
| 26-08-27 | ₹85.02 | +1.74% | 6,257 |
| 26-08-26 | ₹83.57 | -1.94% | 10,024 |
| 26-08-25 | ₹85.22 | +0.04% | 4,675 |
| 26-08-24 | ₹85.19 | -0.86% | 8,338 |
- Stock Market
- Stocks
- BALPHARMA Stock
- BALPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
















